[ad_1]
This formulation alleviates the effects after the injection process so as not to cause swollen hands. In fact, it was approved by the Food and Drug Monitoring Agency (BPOM) on May 23, 2018.
"Before, the medical staff had to find the vein location before they could." 39, go to the injection.Now, it is easier. Dr. Soetomo Surabaya, Mursini
Giving a new formulation is devoted to the type of bad cancer type HER 2 positive. Nevertheless, Nugroho Prayogo, investigator of SafeHER Research, says that he remains balanced with chemotherapy. Coupled with this subcutaneous method, recovery becomes faster and noninvasive.
"In its 2 positive conditions, the cancer becomes more aggressive compared to Luminal A and Luminal B. Not only with chemotherapy alone or with Trastuzumab alone," he said Wednesday (11/7). [19659002] Nugroho says that trastuzumab is able to eliminate the hyaluronidase enzyme that destroys tissues between cells under the skin.Can be injected in large quantities but must be under the supervision of a doctor. This is because the drug has side effects on the heart.So it is not recommended for people with hypertension and other cardiovascular diseases.
Indonesia, the number of bad cancer patients is about 42%, so we need to make a breakthrough .In Indonesia, we need to look at some aspects such as differences in height and weight and the Body condition, "said Abdul Kadir, director of the Dh Cancer Hospital Armaism
. Reporter: ASH
Editor: Bernadetta Febriana
Source link
